NASDAQ · LYEL
Lyell Immunopharma, Inc.
Healthcare · Biotechnology
$10.88
Down-$0.16 (-1.45%)
Updated Nov 3, 2026, 2:29 AM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 708.04M
- P/E ratio
- -1.87
- Dividend yield
- 0.00%
- 52-week range
- $7.20 – $45.00
- Volume
- 104.31K
- Avg. volume
- 48.46K
Price performance · LYEL
LYEL price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 2, 2026
LYEL closed at $10.88 after 21 trading sessions, up 19.96% for the selected period.
- Last close
- $10.88
- Period change
- +19.96%
- Period low
- $7.51
- Period high
- $11.31
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 2, 2026 | $11.04 | $11.40 | $10.56 | $10.88 | 104.31K |
| Oct 30, 2026 | $11.26 | $11.425 | $10.79 | $11.04 | 113.26K |
| Oct 29, 2026 | $11.00 | $11.62 | $11.00 | $11.305 | 149.22K |
| Oct 28, 2026 | $10.01 | $11.03 | $9.84 | $10.93 | 156.81K |
| Oct 27, 2026 | $9.34 | $10.14 | $9.26 | $10.12 | 127.91K |
| Oct 26, 2026 | $9.35 | $9.42 | $9.075 | $9.31 | 85.22K |
| Oct 23, 2026 | $9.33 | $9.445 | $9.05 | $9.39 | 101.64K |
| Oct 22, 2026 | $9.40 | $9.69 | $9.27 | $9.38 | 93.16K |
| Oct 21, 2026 | $9.65 | $10.12 | $9.29 | $9.41 | 118.32K |
| Oct 20, 2026 | $8.74 | $10.01 | $8.565 | $9.70 | 158.62K |
| Oct 19, 2026 | $8.00 | $9.05 | $7.92 | $8.80 | 212.92K |
| Oct 16, 2026 | $8.24 | $8.44 | $7.9214 | $8.12 | 194.96K |
| Oct 15, 2026 | $8.00 | $8.44 | $7.76 | $8.19 | 324.99K |
| Oct 14, 2026 | $7.42 | $8.285 | $7.195 | $7.99 | 402.24K |
| Oct 13, 2026 | $8.27 | $8.27 | $7.39 | $7.51 | 187.17K |
| Oct 12, 2026 | $8.63 | $8.69 | $8.23 | $8.27 | 100.39K |
| Oct 9, 2026 | $8.72 | $9.10 | $8.615 | $8.71 | 106.81K |
| Oct 8, 2026 | $8.49 | $8.845 | $8.21 | $8.79 | 194.72K |
| Oct 7, 2026 | $8.48 | $8.95 | $8.38 | $8.56 | 184.67K |
| Oct 6, 2026 | $9.13 | $9.13 | $8.585 | $8.61 | 125.04K |
| Oct 5, 2026 | $9.27 | $9.31 | $8.66 | $9.07 | 129.45K |
Latest LYEL news
The latest Smart Investors Daily articles mentioning LYEL.
Stock researchMarket Activity · Options
Company
Market Activity
Research & News

